573 related articles for article (PubMed ID: 11480812)
1. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
[TBL] [Abstract][Full Text] [Related]
2. s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study.
Rhodus N; Dahmer L; Lindemann K; Rudney J; Mathur A; Bereuter J
Clin Oral Investig; 1998 Dec; 2(4):191-6. PubMed ID: 10388393
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome.
van der Reijden WA; van der Kwaak JS; Veerman EC; Nieuw Amerongen AV
Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):335-40. PubMed ID: 8930579
[TBL] [Abstract][Full Text] [Related]
4. Progression of salivary gland dysfunction in patients with Sjogren's syndrome.
Pijpe J; Kalk WW; Bootsma H; Spijkervet FK; Kallenberg CG; Vissink A
Ann Rheum Dis; 2007 Jan; 66(1):107-12. PubMed ID: 16728458
[TBL] [Abstract][Full Text] [Related]
5. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
Rhodus NL
Oral Dis; 1997 Jun; 3(2):93-8. PubMed ID: 9467349
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjögren's syndrome: salivary gland function and clinical oral findings.
Pedersen AM; Reibel J; Nordgarden H; Bergem HO; Jensen JL; Nauntofte B
Oral Dis; 1999 Apr; 5(2):128-38. PubMed ID: 10522209
[TBL] [Abstract][Full Text] [Related]
7. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
Grisius MM; Bermudez DK; Fox PC
J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
[TBL] [Abstract][Full Text] [Related]
8. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Khurshudian AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
[TBL] [Abstract][Full Text] [Related]
9. Periodontal conditions of individuals with Sjögren's syndrome.
Antoniazzi RP; Miranda LA; Zanatta FB; Islabão AG; Gustafsson A; Chiapinotto GA; Oppermann RV
J Periodontol; 2009 Mar; 80(3):429-35. PubMed ID: 19254127
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
Hayashi Y; Haneji N; Hamano H
Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
[TBL] [Abstract][Full Text] [Related]
11. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patients wearing complete dentures and in patients with Sjogren's syndrome.
Márton K; Boros I; Fejérdy P; Madléna M
J Prosthet Dent; 2004 Jun; 91(6):577-81. PubMed ID: 15211301
[TBL] [Abstract][Full Text] [Related]
13. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis.
de Souza TR; de Albuquerque Tavares Carvalho A; Duarte ÂP; Porter SR; Leão JC; Gueiros LA
J Oral Pathol Med; 2014 Jul; 43(6):418-26. PubMed ID: 24393164
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G
Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664
[TBL] [Abstract][Full Text] [Related]
15. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort.
Baer AN; Medrano L; McAdams-DeMarco M; Gniadek TJ
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1554-9. PubMed ID: 26867144
[TBL] [Abstract][Full Text] [Related]
16. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
Zipp MM; Yasbin L; al-Hashimi I
Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
[TBL] [Abstract][Full Text] [Related]
17. Sarcoidosis and Sjögren's syndrome: clinical and salivary evaluation.
Mansour MJ; He C; Al-Farra ST; Khuder SA; Wright JM; Kessler HP; Hinton RJ; Al-Hashimi I
J Oral Pathol Med; 2013 Sep; 42(8):594-9. PubMed ID: 23480241
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers.
Tishler M; Yaron I; Shirazi I; Yaron M
Ann Rheum Dis; 1999 Apr; 58(4):253-6. PubMed ID: 10364906
[TBL] [Abstract][Full Text] [Related]
19. Elevated cytokine levels in tears and saliva of patients with primary Sjögren's syndrome correlate with clinical ocular and oral manifestations.
Chen X; Aqrawi LA; Utheim TP; Tashbayev B; Utheim ØA; Reppe S; Hove LH; Herlofson BB; Singh PB; Palm Ø; Galtung HK; Jensen JCL
Sci Rep; 2019 May; 9(1):7319. PubMed ID: 31086200
[TBL] [Abstract][Full Text] [Related]
20. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
